Soligenix (SNGX)


Mature pipeline of biopharmaceuticals for rare diseases. Government funding for biodefense business.


Soligenix is a two-segment business. They have a biotherapeutics rare disease segment focused on cancer, cancer supportive care and inflammation and a separate vaccine/biodefense segment of business funded entirely by the U.S. government, focused on medical countermeasures for military and civilian use.

See Soligenix’s Profile.



Categories: PROFILES